Patents

Bolder BioTechnology files patent applications seeking broad protection for products and technologies that arise from its proprietary research efforts. Our patent applications typically are filed in the United States, Europe, Japan and many other foreign countries to maximize partnering opportunities. Bolder BioTechnology owns exclusive rights to the following issued patents:

United States Patents
Patent Number 7,306,931. Methods for refolding proteins containing free cysteine residues.

Patent Number 7,309,781 Cysteine variants of granulocyte colony-stimulating factor.

Patent Number 7,314,921 Cysteine variants of erythropoietin.

Patent Number 7,270,809 Cysteine variants of alpha interferon-2.

Patent Number 7,253,267. Cysteine variants of interleukin-11.

Patent Number 7,232,885. Termini cysteine-added variants of granulocyte colony- stimulating factor.

Patent Number 7,214,779. Termini cysteine-added variants of granulocyte-macrophage colony stimulating factor.

Patent Number 7,148,333. Cysteine variants of granulocyte-macrophage colony-stimulating factor.

Patent Number 7,153,943. Derivatives of growth hormone and related proteins, and methods of use thereof.

Patent Number 6,608,183. Derivatives of growth hormone and related proteins.

Patent Number 6,753,165. Methods for making proteins containing free cysteine residues.

Foreign Patents
European Patent Number 1 012 184. Derivatives of growth hormone and related proteins.

European Patent Number 1 284 987. Methods for refolding proteins containing free cysteine residues.

Australia Patent Number 2002306305. Derivatives of granulocyte-macrophage colony-stimulating factor.

Australia Patent Number 2001274853. Methods for refolding proteins containing free cysteine residues.

Australia Patent Number 782,496. Immunoglobulin fusion proteins.

Australia Patent Number 751,898. Derivatives of growth hormone.

Australia Patent Number 775,937. Methods for making proteins containing free cysteine residues.

New Zealand Patent Number 535,718. Methods for refolding anti-angiogenesis proteins containing free cysteine residues.

New Zealand Patent Number 502,375. Derivatives of growth hormone and related proteins.

New Zealand Patent Number 513,077. Methods for making proteins containing free cysteine residues.

New Zealand Patent Number 517,184. Immunoglobulin fusion proteins.

New Zealand Patent Number 522,847. Methods for refolding proteins containing free cysteine residues.

China Patent Number 00808841.1. Methods for making proteins containing free cysteine residues.

China Patent Number 01812855.6. Methods for refolding proteins containing free cysteine residues.

Korea Patent Number 0731826. Methods for making proteins containing free cysteine residues.